Detection of human immunodeficiency virus type 1 and type 2 in the female genital tract: Implications for the understanding of virus transmission

Obstetrical and Gynecological Survey

Volumn 52, Issue 5, 1997, Pages 315-324

  Critchlow, Cathy W ^a   Kiviat, Nancy B ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; PLACENTAL TRANSFER; REVIEW; SEXUAL TRANSMISSION; VAGINA SECRETION; VIRUS DETECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ADULT; BIOLOGICAL MARKERS; CERVIX UTERI; DISEASE TRANSMISSION, HORIZONTAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; INFANT, NEWBORN; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; VAGINA; VAGINAL SMEARS;

EID: 0030985242     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-199705000-00024     Document Type: Review

References (73)

1. Evans AS. Epidemiologic concepts and methods. In: Evans AS, ed. Viral Infections of Humans. Epidemiology and Control, 3rd Ed. New York: Plenum Medical Book Co, 1991, pp 3-49.
2. Hughes A, Corrah T. Human immunodeficiency virus type 2 (HIV-2). Blood Rev 1990;4:158-164.
3. Guyader M, Emerman M, Sonigo P et al. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 1987;326:662-669.
4. Kanki P, M'Boup S, Marlink R et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in West African female prostitutes. Am J Epidemiol 1992;136(7):895-907.
5. De Cock KM, Porter A, Kouadio J et al. Cross-reactivity on Western blots in HIV-1 and HIV-2 infections. AIDS 1991;5: 859-863.
6. Travers K, Mboup S, Marlink R et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-1615.
7. O'Brien TR, George R, Holmberg SD. Human immunodeficiency virus type 2 infection in the United States. J Am Med Assoc 1992;267:2775-2779.
8. De Cock KM, Brun-Vézinet F. Epidemiology of HIV-2 infection. AIDS 1989;3(Suppl 1):S89-S95.
9. Markovitz D. Infection with the human immunodeficiency virus type 2. Ann Intern Med 1993;118:211-218.
10. Abbott RC, Ndour-Sarr A, Diouf A et al. Risk factors for HIV-1 and HIV-2 infection in pregnant women in Dakar, Senegal. J Acquir Immune Defic Syndr 1994;7:711-717.
11. Pison G, Le Guenno B, Lagarde E et al. Seasonal migration: A risk factor for HIV infection in rural Senegal. J Acquir Immune Defic Syndr 1993;6:196-200.
12. Kane F, Alary M, Ndoye I et al. Temporary expatriation is related to HIV-1 infection in rural Senegal. AIDS 1993;7:1261-1265.
13. Wilkins A, Hayes R, Alonso P et al. Risk factors for HIV-2 infection in the Gambia. AIDS 1991;5:1127-1132.
14. Poulsen A-G, Aaby P, Gottschau A et al. HIV-2 infection in Bissau, West Africa, 1987-1989: Incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr 1993;6: 941-948.
15. Kawamura M, Yamazaki S, Ishikawa K et al. HIV-2 in West Africa in 1966 [lettr]. Lancet 1989;1:385.
16. Kanki PJ, Travers KU, Mboup S et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-946.
17. Morgan G, Wilkins HA, Pepin J et al. AIDS following mother-to-child transmission of HIV-2. AIDS 1990;4:879-882.
18. Lallemant MJ, Lallemant-Le Coeur S, Nzingoula S. Perinatal transmission of HIV in Africa. In: Essex M, Mboup S, Kanki PJ et al., eds. AIDS in Africa. New York: Raven Press, 1994, pp 211-236.
19. Donnelly C, Leisenring W, Kanki P et al. Comparison of transmission rates of HIV-1 and HIV-2 in a cohort of prostitutes in Senegal. Bull Math Biol 1993;55:731-743.
20. DelMistro C, Chotard A, Hall AJ et al. HIV-1 and HIV-2 seroprevalence rates in mother-child pairs living in The Gambia (West Africa). J Acquir Immune Defic Syndrome 1992;5:19-24.
21. De Cock KM, Adjorlolo G, Ekpini E et al. Epidemiology and transmission of HIV-2: why there is no HIV-2 pandemic. J Am Med Assoc 1993;270(17):2083-2086.
22. Simon F, Matheron S, Tamalet C et al. Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993;7:1411-1417.
23. Berry N, Ariyoshi K, Jobe O et al. HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals. AIDS Res Hum Retroviruses 1994;10:1031-1037.
24. Farizo KM, Buehler JW, Chamberland ME et al. Spectrum of disease in persons with human immunodeficiency virus in the United States. J Am Med Assoc 1992;267:1798-1805.
25. Fleming AF. Opportunistic infections in AIDS in developed and developing countries. Trans R Soc Trop Med Hyg 1990; 84(Suppl 1):1-6.
26. De Cock KM, Odehouri K, Colebunders RL et al. A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Côte d'Ivoire. AIDS 1990;4:443-448.
27. Le Guenno BM, Barabe P, Griffet PA et al. HIV-2 and HIV-1 AIDS cases in Senegal: Clinical patterns and immunological perturbations. J Acquir Immune Defic Syndr 1991;4:421-427.
28. Kayembe KP, Nelson AM, Colebunders RL. Opportunistic infections and diseases. In: Essex M, Mboup S, Kanki PJ et al., eds. AIDS in Africa. New York: Raven Press, 1994, pp 373-391.
29. Marlink R, Kanki P, Thior I et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-1590.
30. Pepin J, Morgan G, Dunn D et al. HIV-2 induced immunosuppression among asymptomatic West African prostitutes: Evidence that HIV-2 is pathogenic, but less so than HIV-1. AIDS 1991;5:1165-1172.
31. Dickover RE, Garratty EM, Herman SA et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. J Am Med Assoc 1996;275:640-641.
32. Khouri YF, McIntosh K, Cavacini L et al. Vertical transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies. J Clin Invest 1995;95:732-737.
33. O'Shea S, Cordery M, Barrett WY et al. HIV excretion patterns and specific antibody responses in body fluids. J Med Virol 1990;31:291-296.
34. Rasheed S, Li Z, Xu D. Human immunodeficiency virus load. Quantitative assessment in semen from seropositive individuals and in spiked seminal plasma. J Reprod Med 1995;40: 747-757.
35. Vernazza PL, Eron JJ, Cohen MS et al. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994;8:1325-1329.
36. Kappes JC, Saag MS, Shaw GM et al. Assessment of antiretroviral therapy by plasma viral load testing: Standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:139-149.
37. Connor EM, Sperling RS, Gelber R et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
38. Fielding KL, Brettle RP, Gore SM et al. Heterosexual transmission of HIV analysed by generalized estimating equations. Stat Med 1995;14:1365-1378.
39. Nicolosi A, Musicco M, Saracco A et al. Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. Italian Study Group on HIV Heterosexual Transmission. J Acquir Immune Defic Syndr 1994;7:296-300.
40. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341-346.
41. Venet A, Lu W, Beldjord K et al. Correlation between CD4 cell counts and cellular and plasma viral load in HIV-1-seropositive individuals. AIDS 1991;5:283-238.
42. Kiviat NB, Paavonen J, Wolner-Hanssen P et al. Histopathology of endocervical infections caused by C. trachomatis, HSV, and N. gonorrhoeae. Hum Pathol 1990;21:831-837.
43. Burk RD, Kadish AS, Calderin S et al. Human papillomavirus infection of the cervix detected by cervicovaginal lavage and molecular hybridization: Correlation with biopsy results and Papanicolaou smear. Am J Obstet Gynecol 1986;154:982-989.
44. Poss M, Martin HL, Kreiss JK et al. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 1995;69:8118-8122.
45. Safrit JT, Andrews CA, Zhu T et al. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: Recognition of autologous virus sequences within a conserved immunodominant epitope. J Exp Med 1994;172:463-472.
46. Arens M. Use of probes and amplification techniques for the diagnosis and prognosis of human immunodeficiency virus (HIV-1) infections. Diagn Microbiol Infect Dis 1993;16:165-172.
47. Mulder J, McKinney N, Christopherson C et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection. J Clin Microbiol 1994;32(2):292-300.
48. Piatak Jr M, Saag MS, Yang LC et al. High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993;259:1749-1754.
49. Vogt M, Witt DJ, Craven DE et al. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet 1986;1:525-527.
50. Wofsy CB, Cohen JB, Hauer LB et al. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet 1986;1:527-529.
51. Archibald DW, Witt DJ, Craven DE et al. Antibodies to human immunodeficiency virus in cervical secretions from women at risk for AIDS. J Infect Dis 1987;156:240-241.
52. Vogt M. Witt DJ, Craven DE. Isolation patterns of human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for AIDS. Ann Intern Med 1987;106:380-382.
53. Kreiss J, Coombs R, Plummer F et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989;160:380-384.
54. Hénin Y, Mandelbrot L, Henrion R et al. Virus excretion in the cervicovaginal sections of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndrome 1993;6: 72-75.
55. Wainberg MA, Beaulieu R, Tsoukas C et al. Detection of zidovudine-resistant variants of HIV-1 in genital fluids [lettr]. AIDS 1993;7:433-434.
56. Van de Perre P, de Clercq A, Cogniaux-Leclerc J et al. Detection of HIV p17 antigen in lymphocytes but not epithelial cells from cervicovaginal secretions of women seropositive for HIV: Implications for heterosexual transmission of the virus. Genitourin Med 1988;64:30-33.
57. Bélec L, Matta M, Payan C et al. Human immunodeficiency virus type 1 p24 antigen in cervicovaginal secretions. J Infect Dis 1995;171:1615-1618.
58. Clemetson DBA, Moss G, Willerford D et al. Detection of HIV DNA in cervical and vaginal secretions. J Am Med Assoc 1993;269:2860-2864.
59. Zorr B, Schäfer APA, Dilger I et al. HIV-1 detection in endocervical swabs and mode of HIV-1 infection [lettr]. Lancet 1994;343:852.
60. Kreiss J, Willerford DM, Hensel M et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994;170:1597-1601.
61. Vernon SD, Zaki SR, Reeves WC. Localization of HIV-1 to human papillomavirus associated cervical lesions [lettr]. Lancet 1994;344:955-956.
62. Pomerantz RJ, de la Monte SM, Donegan SP et al. Human immunodeficiency virus (HIV) infection of the uterine cervix. Ann Intern Med 1988;108:321-327.
63. Nuovo GJ, Forde A, MacConnell P et al. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol 1993;143:40-48.
64. Braathen LR, Ramirez G, Kunze RO et al. Langerhans cells as primary target cells for HIV infection [lettr]. Lancet 1987; 2(8567):1094.
65. Bélec L, Georges AJ, Steenman G et al. Antibodies to human immunodeficiency virus in vaginal secretions of heterosexual women. J Infect Dis 1989;160:385-391.
66. Bélec L, Peghini M, Georges AJ et al. Antibodies to HIV-2 in genital secretions. Res Virol 1989b;140:15-21.
67. Lu X-S, Bélec L, Martin PMV et al. Enhanced local immunity in vaginal secretions of HIV-infected women. Lancet 1991;338: 323-324.
68. Lu X-S, Bélec L, Pillot J. Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG in cervicovaginal secretions from human immunodeficiency virus type 1-infected women. J Infect Dis 1993;167:1189-1192.
69. Bélec L, Tévi-Bénissan C, Grésenguet G et al. HIV-1 antibody serum negativity with vaginal secretions positivity. Lancet 1994;343:1046-1047.
70. Bélec L, Grésenguet G, Dragon M-A et al. Detection of antibodies to human immunodeficiency virus in vaginal secretions by immunoglobulin G antibody capture enzyme-linked immunosorbent assay: Application to detection of seminal antibodies after sexual intercourse. J Clin Microbiol 1994;32:1249-1255.
71. Bélec L, Dupré T, Prazuck T et al. Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgG local response in HIV infection. J Infect Dis 1995;172:691-697.
72. Bélec L, Meillet D, Gaillard O et al. Decreased cervicovaginal production of both IgA1 and IgA2 subclassses in women with AIDS. Clin Exp Immunol 1995;101:100-106.
73. Bélec L, Tévi-Bénissan C, Lu X-S et al. Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection. AIDS Res Hum Retroviruses 1995;11:719-729.